|
SLNO Soleno Therapeutics Inc 1484565 |
| Balance Sheet |
|
Current Assets
|
258,199,000 |
|
Assets
|
296,706,000 |
|
Current Liabilities
|
14,962,000 |
|
Liabilities
|
32,007,000 |
|
Equity
|
264,699,000 |
|
Shares Out
|
38,872,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-45,105,000 |
|
Investing Cash Flow
|
-232,125,000 |
| Market Analysis |
Market Cap
|
2,047,755,373 |
|
Price
|
46.88 |
|
BVPS
|
6.81 |
|
PB
|
6.87 |
|
EPS
|
-2.43 |
|
PS
|
0.30 |
|
FCF
|
-277,230,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLNO documents filed with the SEC.
SLNO Filings
Clear
